Volume 9, Issue 9 - September 2022
Bidding Farewell To a Very Successful Congress
ISDE 2022 came to a very successful close this week! Three days of Congress activities attracted more than 550 attendees and offered tremendous opportunities for education and networking through 50+ scientific sessions and 500+ abstract presentations.

The ISDE video portal with all ISDE2022 sessions remains available to conference registrants to watch on-demand until December 31, 2022. Virtual platform FAQ's can be viewed here.

ISDE would like to extend sincere appreciation to all attendees, speakers, contributors and committee members for making ISDE 2022 the extraordinary success that it was! A special thank you is extended to Professor Hideaki Shimada of the Japanese Esophageal Society (JES) for his exceptional assistance, support and partnership.
Plan NOW for 2023 in Toronto, Canada
Start planning and budgeting now for the 19th ISDE World Congress in Toronto, Canada September 8-10, 2023 - a world-class city that will not disappoint!
Thank You to Outgoing ISDE Directors

ISDE flourishes as a result of the dedication and commitment from many volunteers. Sincere thanks is extended to the following ISDE Directors for their time, effort and wealth of expertise over the years to not only help ISDE grow, but to thrive well into the future.
Introducing the Young ISDE Committee
Sheraz Markar
Chair
Jessie Elliott
Secretary
David Liu
Vice Chair
ISDE is committed to the advancement and support of trainees, fellows and early career individuals. To this end we are pleased to introduce the formation of Young ISDE, a new standing committee within the ISDE. The chair, vice chair and secretary are very excited and committed to the following goals:
  • The development of new knowledge and advanced understanding of esophageal diseases
  • Promoting education and knowledge exchange among trainees and young investigators
  • Facilitating connections
  • Advertising training and fellowship opportunities


Join the Young ISDE subscriber list here and stay up-to-speed on all things Young ISDE!
Giovanni Zaninotto Bids Farewell as DOTE Editor-in-Chief
"On 29 September 2022, I will step down as co-editor in Chief (Surgery) of Diseases of the Esophagus. I started 8 years ago, and when I think about this long period dedicated to the Journal, I feel a mix of emotions. It has been one of the greatest honors of my professional life to be appointed in 2014 as the Co-Editor in Chief (surgery) of the Journal, and I wish to thank ISDE for trusting me with this privilege. I must confess that I would like to undertake this burden for many more years; still, this Journal, like all human institutions, needs continuous stimulation, change, and renovation to keep it at the forefront of its specialized area. The new editor will bring new ideas and enthusiasm to enhance DOTE’s quality further."

Congratulations to DOTE Award Winners
Each year, Diseases of the Esophagus provides two awards:

  1. Best Junior Faculty/Trainee Manuscript Award to the top original research manuscript by a junior faculty or trainee author accepted for publication in the journal in 2021.
  2. Outstanding Junior Faculty Peer Reviewer Award to the top junior faculty Peer Reviewer of 2021 for the journal.

Congratulations to this year's winners:
Dr. Alice Tsai
Imperial College Healthcare NHS Trust, England 

The latest issue of Diseases of the Esophagus Journal is now available online.

Subscribe to DOTE email alerts.
ISDE 2022 DOTE Congress Supplement
Volume 35, Issue Supplement 2, September 2022
Take a moment to go through the ISDE 2022 DOTE Congress Supplement. Abstracts submitted to the 18th ISDE World Congress for Esophageal Diseases are now available online. See the full list of abstracts here.
Editor's Choice - Original Article
Gastroesophageal anastomotic leakage (AL) is one of the most common postoperative complications of esophageal cancer, exerting the greatest impact on the postoperative rehabilitation of patients. Over the last decades, neoadjuvant therapies have significantly improved the long-term survival and R0 resection rates for resectable esophageal cancer. However, at the same time, surgeons are also concerned about whether the postoperative complications rate of patients will increase after neoadjuvant therapy combined with surgery, such as gastroesophageal AL.


Editor's Choice

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated inflammatory disease of the esophagus commonly complicated by and presenting as esophageal food impaction (EFI). In many studies, EoE is the most common cause of EFI in patients presenting to the emergency department (ED) Despite the increasing disease burden of EoE, EoE-related EFI, and risks of EFI few studies have identified best practices for management of EFI in patients with established or suspected EoE.

EoE-related EFI poses several important considerations. First, EFI may represent the initial presentation of EoE and should raise a high index of suspicion for this diagnosis. Second, EoE-related EFI can occur in the setting of active mucosal inflammation or chronic remodeling and stricture each of which requires a different therapeutic approach. Third, because EoE is a chronic condition, disimpaction may have been performed previously and, consequently, approaches may vary based on prior outcomes with dilation. Each of these factors may influence care before, during and after endoscopic assessment and treatment.

Literature Updates




 
 
 









Visit the ISDE Literature Updates Online for more.

Follow ISDE on Social Media
CONTACT US: membership@isde.net | 604.638.3862